ACIU - AC Immune Inc Growth-Adjusted Payback Ratio
Swiss biopharma AC Immune (ACIU) develops vaccines against neurodegeneration based on tau protein diagnostics. The PEG ratio on the current GURU.Markets platform chart illustrates the asset's dynamics, where the value 0.00 represents the current metric. A transparent R&D plan under the guidance of competent management is combined with a minimal environmental footprint and strict chemical safety standards in the laboratories.
AC Immune (ACIU) - metric breakdowns and financial figures
- market price and analyst price targets:
- market capitalization statistics:
- book capitalization indicators:
- debt obligations and liquidity statistics:
- net income and valuation ratios data:
ACIU - Net Profit|Future Profit AC Immune|ACIU - P/E Multiple|Market Cap to Projected Earnings AC Immune Inc|ACIU - Price/Earnings to Growth Multiple|EV/EBITDA Multiple AC Immune Corp|ACIU - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months AC Immune|ACIU - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months acimmune.com|ACIU - Net earnings per share growth this year|Earnings growth forecast for next year AC Immune
Fundamental company analysis:AC Immune S.A. (ACIU)
This indicator compares the market value of earnings with their growth rate to determine the extent of the premium paid for future business expansion. The price-to-earnings-to-EPS-growth ratio allows for an assessment of whether the current discount compensates for the binary risks of AC Immune (ACIU), stemming from its narrow specialization in Alzheimer's disease therapy and dependence on clinical trial outcomes.
Competing companies
Price/Earnings to Growth Multiple Biogen Inc BIIB|Neurocrine Biosciences Inc - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio RGC|Axsome Therapeutics - PEG Multiple|Growth-Adjusted Market Cap to Net Income acadia-pharm.com ACAD|Xenon (XENE) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Viking Therapeutics Inc|Price/Earnings to Growth Ratio Supernus Pharma|Price/Earnings to Growth Multiple Catalyst Corp (CPRX)|Price/Earnings to Growth Multiple DNLI (Denali Therapeutics)|PEG Multiple harmonybiosciences.com (HRMY)|Price/Earnings to Growth Ratio Biohaven BHVN|AMLX: Growth-Adjusted P/E Ratio|Trevi Pharma - PEG Multiple|Price to Earnings Adjusted for Growth Rate Praxis Corp|AVXL: PEG Multiple|ceribell.com (CBLL) - PEG Multiple|PRTA (Prothena Corporation plc) - PEG Multiple|Price/Earnings to Growth Multiple Alector Therapeutics (ALEC)|PEG Multiple ANNX|Growth-Adjusted Market Cap to Net Income omeros.com|Neurogene Inc. - Price/Earnings to Growth Multiple|PEG Multiple voyagertherapeutics.com VYGR|NMRA - Price/Earnings to Growth Ratio|SCLX (Scilex Holding) - Growth-Adjusted P/E Ratio|TVGN: PEG Multiple|Price to Earnings Adjusted for Growth Rate Alpha Cognition Inc. (ACOG)|Price/Earnings to Growth Multiple CGTX|PEG Multiple inhibikase.com|Price/Earnings to Growth Ratio Cassava Sciences (SAVA)|ASRT (assertiotx.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Coya Therapeutics COYA|VistaGen Therapeutics, Inc. (VTGN) - Price to Earnings Adjusted for Growth Rate|Ovid Rx - PEG Multiple|ABOS - PEG Multiple|CRVO: PEG Multiple|Price/Earnings to Growth Multiple Alterity Therapeutics Limited|Price/Earnings to Growth Multiple CLNN|PEPG: Growth-Adjusted Payback Ratio|PEG Multiple JUNS|Growth-Adjusted Market Cap to Net Income relmada.com|Price/Earnings to Growth Ratio Annovis Bio ANVS|GRCE - Price/Earnings to Growth Multiple|AIFF - Price/Earnings to Growth Ratio|Klotho Neurosciences Inc (KLTO) - Price/Earnings to Growth Multiple|NRSN (neurosense-tx.com) - Price/Earnings to Growth Multiple|revivapharma.com (RVPH) - PEG Multiple|Price/Earnings to Growth Ratio MetaVia Inc.|Growth-Adjusted P/E Ratio NRXS (NeurAxis Inc.)|PEG Multiple HSDT|PASG - Price to Earnings Adjusted for Growth Rate|PEG Multiple NEUP (Neuphoria Therapeutics)|PEG Multiple minervaneurosciences.com NERV|Athira Pharma - PEG Multiple|Addex Therapeutics Ltd. (ADXN) - Price/Earnings to Growth Multiple|ALZN: PEG Multiple|CYCN - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple PTIX|PEG Multiple Pasithea|Price/Earnings to Growth Ratio Cortigent, Inc. (CRGT)|Avenue Therapeutics Inc. - Growth-Adjusted P/E Ratio|PEG Multiple BCLI (Brainstorm Cell Therapeutics, Inc.)|Cara Therapeutics Inc (CARA) - Price to Earnings Adjusted for Growth Rate|CHRO: Price/Earnings to Growth Multiple|ELYM - PEG Multiple|intracellulartherapies.com (ITCI) - Price/Earnings to Growth Ratio|Longboard Pharmaceuticals Inc - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Marinus|Price to Earnings Adjusted for Growth Rate NKGen Biotech Corp NKGN|PEG Multiple NRBO|PEG Multiple sagerx.com (SAGE)|PEG Multiple SNPX (Synaptogenix)|TRVN - Price/Earnings to Growth Multiple|VIGL: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio WENA (Anew Medical Inc.)|CERE: PEG Multiple
